NEWS
October 2010 -
November 2009 -
August 2009 -
March 2008 -
October 2007 -
November 2009 -
August 2009 -
March 2008 -
October 2007 -
HPRL Awarded Qualifying Therapeutic Discovery Tax Grants for two of its on-going research programs; "Novel Inhibitors for the Treatment of Highly Drug-Resistant Chronic Myelogenous Leukemia" and "Discovery and Development of Anti-Diabetic Drugs."
Dr. Charles Sawyers shares the 2009 Lasker Award for his work elucidating the mechanism of drug-resistance in Chronic Myelogenous Leukemia (CML).
HPRL Awarded Phase I Small Business Innovation Research (SBIR) Grant for "Novel Inhibitors for the Treatment of Highly Drug-Resistant Chronic Myelogenous Leukemia (CML)."
HPRL Awarded Phase II Small Business Innovation Research (SBIR) Grant for the "Discovery and Development of Anti-Diabetic Drugs."
The Juvenile Diabetes Research Foundation (JDRF) Partners with HPRL for therapeutic discovery and development in the area of Type I Diabetes.
Dr. Charles Sawyers shares the 2009 Lasker Award for his work elucidating the mechanism of drug-resistance in Chronic Myelogenous Leukemia (CML).
HPRL Awarded Phase I Small Business Innovation Research (SBIR) Grant for "Novel Inhibitors for the Treatment of Highly Drug-Resistant Chronic Myelogenous Leukemia (CML)."
HPRL Awarded Phase II Small Business Innovation Research (SBIR) Grant for the "Discovery and Development of Anti-Diabetic Drugs."
The Juvenile Diabetes Research Foundation (JDRF) Partners with HPRL for therapeutic discovery and development in the area of Type I Diabetes.
MEDICINE FOR THE WORLD'S WELL-BEING
